Learn More
Invitrogen™ EGR1 Recombinant Rat Monoclonal Antibody (HEGR1DS)
Description
Recombinant rat monoclonal antibodies are produced using in vitro expression systems. Recombinant antibodies are produced using specific genes that code for the desired antibodies. These genes are cloned into an expression vector and expressed in vitro. The advantages of recombinant antibodies include better specificity and lot-to-lot consistency. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
Specifications
Specifications
| Antigen | EGR1 |
| Applications | Flow Cytometry, Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | HEGR1DS |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene | EGR1 |
| Gene Accession No. | P18146 |
| Gene Alias | A530045N19Rik; AT225; early growth response 1; early growth response protein 1; egr; EGR1; EGR-1; ETR103; G0S30; Krox-1; Krox24; Krox-24; Krox-24 nuclear protein; Nerve growth factor-induced protein A; Ngf1; NGF1-A; Ngfi; NGFIA; NGFI-A; TIS8; transcription factor ETR103; Transcription factor Zif268; Zenk; Zfp-6; Zif268; zif-268; Zinc finger protein 225; zinc finger protein Krox-24; ZNF225 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.